<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39192882</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1662-5161</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in human neuroscience</Title><ISOAbbreviation>Front Hum Neurosci</ISOAbbreviation></Journal><ArticleTitle>Neurologic manifestations of Long COVID in Colombia: a comparative analysis of post-hospitalization vs. non-hospitalized patients.</ArticleTitle><Pagination><StartPage>1450110</StartPage><MedlinePgn>1450110</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1450110</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnhum.2024.1450110</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To analyze patient-reported outcomes, cognitive function, and persistent symptoms in patients with neurologic post-acute sequelae of SARS-CoV-2 infection (Neuro-PASC) in Colombia.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We recruited patients with laboratory-confirmed COVID-19 and PASC symptoms lasting more than 6&#x2009;weeks at the CES University and CES Clinic (Medell&#xed;n, Colombia). We included 50 post-hospitalization Neuro-PASC (PNP) and 50 non-hospitalized Neuro-PASC (NNP) patients. Long-COVID symptoms, cognitive (NIH Toolbox v2.1-Spanish for 18+), patient-reported (PROMIS) outcomes, and relevant medical history were evaluated. Statistical analyses were performed via generalized linear models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Overall, brain fog (60%), myalgia (42%), and numbness or tingling (41%) were the most common neurological symptoms, while fatigue (74%), sleep problems (46%), and anxiety (44%) were the most common non-neurological symptoms. Compared to NNP, PNP patients showed a higher frequency of abnormal neurological exam findings (64% vs. 42%, <i>p</i>&#x2009;=&#x2009;0.028). Both groups had impaired quality of life (QoL) in domains of cognition, fatigue, anxiety depression and sleep disturbance, and performed worse on processing speed and attention than a normative population. In addition, NNP patients performed worse on executive function than PNP patients (T-score 42.6 vs. 48.5, <i>p</i>&#x2009;=&#x2009;0.012). PASC symptoms of anxiety and depression were associated with worse QoL and cognitive outcomes. Brain fog and fatigue remained persistent symptoms across all durations of Long COVID.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our findings highlight the high incidence and heterogeneity of the neurologic symptoms and impacts of Long COVID even more than 2&#x2009;years from disease onset. Early detection, emotional support and targeted management of Neuro-PASC patients are warranted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Hurtado, Rojas-Gualdr&#xf3;n, P&#xe9;rez Giraldo, Villegas Arbelaez, Medina Mantilla, Campuzano-Sierra, Ospina-Patino, Arroyave-Bustamante, Uribe-Vizcarra, Restrepo-Arbelaez, Cardona, Llano-Piedrahita, V&#xe1;squez-Builes, Agudelo-Quintero, V&#xe9;lez-Arroyave, Menges, Jimenez, Miller, Quique and Koralnik.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hurtado</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-Gualdr&#xf3;n</LastName><ForeName>Diego Fernando</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez Giraldo</LastName><ForeName>Gina S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Neurology Department, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villegas Arbelaez</LastName><ForeName>Esteban</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cl&#xed;nica CES, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantilla</LastName><ForeName>Salvador Ernesto Medina</ForeName><Initials>SEM</Initials><AffiliationInfo><Affiliation>Cl&#xed;nica CES, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campuzano-Sierra</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ospina-Patino</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arroyave-Bustamante</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uribe-Vizcarra</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Restrepo-Arbelaez</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardona</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llano-Piedrahita</LastName><ForeName>Juli&#xe1;n</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;squez-Builes</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agudelo-Quintero</LastName><ForeName>Esteban</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe9;lez-Arroyave</LastName><ForeName>Juliana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menges</LastName><ForeName>Sebasti&#xe1;n</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, CES University, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>Millenia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Ken &amp; Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Janet</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Ken &amp; Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quique</LastName><ForeName>Yina M</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Shirley Ryan AbilityLab, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koralnik</LastName><ForeName>Igor J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>The Ken &amp; Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Hum Neurosci</MedlineTA><NlmUniqueID>101477954</NlmUniqueID><ISSNLinking>1662-5161</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">neurologic manifestations</Keyword><Keyword MajorTopicYN="N">patient reported outcome measures</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>IK receives royalties from UpToDate for a chapter on neurologic manifestations of COVID-19. YQ was employed by Shirley Ryan AbilityLab. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>4</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39192882</ArticleId><ArticleId IdType="pmc">PMC11347330</ArticleId><ArticleId IdType="doi">10.3389/fnhum.2024.1450110</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adler L., Gazit S., Pinto Y., Perez G., Mizrahi Reuveni M., Yehoshua I., et al. . (2022). Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide cohort study. Scand. J. Prim. Health Care 40, 342&#x2013;349. doi: 10.1080/02813432.2022.2139480, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02813432.2022.2139480</ArticleId><ArticleId IdType="pmc">PMC9848375</ArticleId><ArticleId IdType="pubmed">36314555</ArticleId></ArticleIdList></Reference><Reference><Citation>Affairs ASPA . (2023). About Long COVID. Available at: https://www.covid.gov/be-informed/longcovid/about (Accessed February 6, 2024).</Citation></Reference><Reference><Citation>Aghajani Mir M. (2023). Brain fog: a narrative review of the Most common mysterious cognitive disorder in COVID-19. Mol. Neurobiol. doi: 10.1007/s12035-023-03715-y [Epub ahead of print]., PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-023-03715-y</ArticleId><ArticleId IdType="pubmed">37874482</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Moreno C. A., Pineda J., Bare&#xf1;o A., Espitia R., Rengifo P. (2023). Long COVID-19 in Latin America: Low prevalence, high resilience or low surveillance and difficulties accessing health care? Travel Med. Infect. Dis. 51:102492. doi: 10.1016/j.tmaid.2022.102492, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2022.102492</ArticleId><ArticleId IdType="pmc">PMC9640373</ArticleId><ArticleId IdType="pubmed">36368518</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J.-M., Rojas M., Salinas M. L., Rodr&#xed;guez Y., Roa G., Lozano M., et al. . (2021). Post-COVID syndrome. A case series and comprehensive review. Autoimmun. Rev. 20:102947. doi: 10.1016/j.autrev.2021.102947, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Angarita-Fonseca A., Torres-Castro R., Benavides-Cordoba V., Chero S., Morales-Sat&#xe1;n M., Hern&#xe1;ndez-L&#xf3;pez B., et al. . (2023). Exploring long COVID condition in Latin America: its impact on patients&#x2019; activities and associated healthcare use. Front. Med. 10:1168628. doi: 10.3389/fmed.2023.1168628</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1168628</ArticleId><ArticleId IdType="pmc">PMC10157152</ArticleId><ArticleId IdType="pubmed">37153089</ArticleId></ArticleIdList></Reference><Reference><Citation>Babiloni C., Gentilini Cacciola E., Tucci F., Vassalini P., Chilovi A., Jakhar D., et al. . (2024). Resting-state EEG rhythms are abnormal in post COVID-19 patients with brain fog without cognitive and affective disorders. Clin. Neurophysiol. 161, 159&#x2013;172. doi: 10.1016/j.clinph.2024.02.034, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2024.02.034</ArticleId><ArticleId IdType="pubmed">38492271</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J. H., Lin J. J., Twumasi A., Goswami R., Carnavali F., Stone K., et al. . (2023). Greater executive dysfunction in patients post-COVID-19 compared to those not infected. Brain Behav. Immun. 114, 111&#x2013;117. doi: 10.1016/j.bbi.2023.08.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.08.014</ArticleId><ArticleId IdType="pubmed">37586567</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostanci A., Gazi U., Tosun O., Suer K., Unal Evren E., Evren H., et al. . (2023). Long-COVID-19 in asymptomatic, non-hospitalized, and hospitalized populations: a cross-sectional study. JCM 12:2613. doi: 10.3390/jcm12072613, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12072613</ArticleId><ArticleId IdType="pmc">PMC10095523</ArticleId><ArticleId IdType="pubmed">37048697</ArticleId></ArticleIdList></Reference><Reference><Citation>Bota A. V., Bratosin F., Bogdan I., Septimiu-Radu S., Ilie A. C., Burtic S.-R., et al. . (2024). Assessing the quality of life, coping strategies, anxiety and depression levels in patients with long-COVID-19 syndrome: a six-month follow-up study. Diseases 12:21. doi: 10.3390/diseases12010021, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases12010021</ArticleId><ArticleId IdType="pmc">PMC10814582</ArticleId><ArticleId IdType="pubmed">38248372</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga L. W., Oliveira S. B., Moreira A. S., Pereira M. E., Carneiro V. S., Serio A. S., et al. . (2022). Neuropsychological manifestations of long COVID in hospitalized and non-hospitalized Brazilian patients. NRE 50, 391&#x2013;400. doi: 10.3233/NRE-228020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/NRE-228020</ArticleId><ArticleId IdType="pubmed">35599507</ArticleId></ArticleIdList></Reference><Reference><Citation>Castriotta L., Onder G., Rosolen V., Beorchia Y., Fanizza C., Bellini B., et al. . (2024). Examining potential long COVID effects through utilization of healthcare resources: a retrospective, population-based, matched cohort study comparing individuals with and without prior SARS-CoV-2 infection. Eur. J. Public. Health. 34, 592&#x2013;599. doi: 10.1093/eurpub/ckae001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckae001</ArticleId><ArticleId IdType="pmc">PMC11161167</ArticleId><ArticleId IdType="pubmed">38243748</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L., Calandri I., Corval&#xe1;n N., Carello M. A., Keller G., Mart&#xed;nez C., et al. . (2022). Cognitive consequences of COVID-19: results of a cohort study from South America. Arq. Neuropsiquiatr. 80, 240&#x2013;247. doi: 10.1590/0004-282x-anp-2021-0320, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282x-anp-2021-0320</ArticleId><ArticleId IdType="pmc">PMC9648931</ArticleId><ArticleId IdType="pubmed">34816972</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., Assaf G. S., McCorkell L., Wei H., Low R. J., Re&#x2019;em Y., et al. . (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine 38:101019. doi: 10.1016/j.eclinm.2021.101019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto O. H., Wu S., Mera R. M., Costa A. F., Recalde B. Y., Issa N. P. (2021). Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: a longitudinal prospective study nested to a population cohort. Eur. J. Neurol. 28, 3245&#x2013;3253. doi: 10.1111/ene.14775, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14775</ArticleId><ArticleId IdType="pmc">PMC8014083</ArticleId><ArticleId IdType="pubmed">33576150</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C., D&#xed;ez-Cirarda M., Pag&#xe1;n J., P&#xe9;rez-Izquierdo C., Oliver-Mas S., Fern&#xe1;ndez-Romero L., et al. . (2023). Unraveling brain fog in post-COVID syndrome: relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms. Euro J of. Euro J. Neurol.:ene.16084. doi: 10.1111/ene.16084 [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.16084</ArticleId><ArticleId IdType="pubmed">37797297</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVries A., Shambhu S., Sloop S., Overhage J. M. (2023). One-year adverse outcomes among US adults with post&#x2013;COVID-19 condition vs those without COVID-19 in a large commercial insurance database. JAMA Health Forum 4:e230010. doi: 10.1001/jamahealthforum.2023.0010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2023.0010</ArticleId><ArticleId IdType="pmc">PMC9984976</ArticleId><ArticleId IdType="pubmed">36867420</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F., Belati A., Tulone O., Diella L., Fiore Bavaro D., Bonica R., et al. . (2023). Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120, 970 patients. Intern. Emerg. Med. 18, 1573&#x2013;1581. doi: 10.1007/s11739-022-03164-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03164-w</ArticleId><ArticleId IdType="pmc">PMC9709360</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershon R. C., Cella D., Fox N. A., Havlik R. J., Hendrie H. C., Wagster M. V. (2010). Assessment of neurological and behavioural function: the NIH toolbox. Lancet Neurol. 9, 138&#x2013;139. doi: 10.1016/S1474-4422(09)70335-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(09)70335-7</ArticleId><ArticleId IdType="pubmed">20129161</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershon R. C., Wagster M. V., Hendrie H. C., Fox N. A., Cook K. F., Nowinski C. J. (2013). NIH toolbox for assessment of neurological and behavioral function. Neurology 80, S2&#x2013;S6. doi: 10.1212/WNL.0b013e3182872e5f, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182872e5f</ArticleId><ArticleId IdType="pmc">PMC3662335</ArticleId><ArticleId IdType="pubmed">23479538</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Wulf Hanson S., Abbafati C., Aerts J. G., Al-Aly Z., Ashbaugh C., et al. . (2022). Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 328:1604. doi: 10.1001/jama.2022.18931, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman M. L., Molldrem S., Elliott A., Robertson D., Keiser P. (2023). Long COVID and mental health correlates: a new chronic condition fits existing patterns. Health Psychol. Behav. Med. 11:2164498. doi: 10.1080/21642850.2022.2164498</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21642850.2022.2164498</ArticleId><ArticleId IdType="pmc">PMC9833408</ArticleId><ArticleId IdType="pubmed">36643576</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E. L., Clark J. R., Orban Z. S., Lim P. H., Szymanski A. L., Taylor C., et al. . (2021). Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers.&#x201d;. Ann. Clin. Transl. Neurol. 8, 1073&#x2013;1085. doi: 10.1002/acn3.51350, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton R. K., Akshoomoff N., Tulsky D., Mungas D., Weintraub S., Dikmen S., et al. . (2014). Reliability and validity of composite scores from the NIH toolbox cognition battery in adults. J. Int. Neuropsychol. Soc. 20, 588&#x2013;598. doi: 10.1017/S1355617714000241, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617714000241</ArticleId><ArticleId IdType="pmc">PMC4103963</ArticleId><ArticleId IdType="pubmed">24960398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon J., Milne R., Rayner C., Rocha Lawrence R., Mullard J., Mir G., et al. . (2023). Impact of long COVID on productivity and informal caregiving. Eur. J. Health Econ. doi: 10.1007/s10198-023-01653-z [Epub ahead of print]., PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-023-01653-z</ArticleId><ArticleId IdType="pmc">PMC11377524</ArticleId><ArticleId IdType="pubmed">38146040</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.-S., Cella D., Choi S., Junghaenel D. U., Christodoulou C., Gershon R., et al. . (2011). How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item Bank example. Arch. Phys. Med. Rehabil. 92, S20&#x2013;S27. doi: 10.1016/j.apmr.2010.08.033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2010.08.033</ArticleId><ArticleId IdType="pmc">PMC3696589</ArticleId><ArticleId IdType="pubmed">21958919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.-S., Wagner L. I., Jacobsen P. B., Cella D. (2014). Self-reported cognitive concerns and abilities: two sides of one coin?: cognitive concerns versus cognitive abilities. Psycho-Oncology 23, 1133&#x2013;1141. doi: 10.1002/pon.3522, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.3522</ArticleId><ArticleId IdType="pmc">PMC4185008</ArticleId><ArticleId IdType="pubmed">24700645</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitner M., P&#xf6;tz G., Berger M., Fellner M., Spat S., Koini M. (2024). Characteristics and burden of acute COVID-19 and long-COVID: demographic, physical, mental health, and economic perspectives. PLoS One 19:e0297207. doi: 10.1371/journal.pone.0297207, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0297207</ArticleId><ArticleId IdType="pmc">PMC10802963</ArticleId><ArticleId IdType="pubmed">38252638</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID-Household Pulse Survey-COVID-19  (2024). Available at: https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm (Accessed February 28, 2024).</Citation></Reference><Reference><Citation>L&#xf3;pez-L&#xf3;pez L., Calvache-Mateo A., Ortiz-Rubio A., Granados-Santiago M., Heredia-Ciur&#xf3; A., Mart&#xed;n-N&#xfa;&#xf1;ez J., et al. . (2023). Differences of disabling symptoms between previously hospitalized or non-hospitalized currently working long-COVID survivors one year after infection: a descriptive study. Healthcare 11:2306. doi: 10.3390/healthcare11162306, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11162306</ArticleId><ArticleId IdType="pmc">PMC10454028</ArticleId><ArticleId IdType="pubmed">37628505</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainous A. G., Rooks B. J., Wu V., Orlando F. A. (2021). COVID-19 post-acute sequelae among adults: 12 month mortality risk. Front. Med. 8:778434. doi: 10.3389/fmed.2021.778434, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.778434</ArticleId><ArticleId IdType="pmc">PMC8671141</ArticleId><ArticleId IdType="pubmed">34926521</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchi M., Grenzi P., Serafini V., Capoccia F., Rossi F., Marrino P., et al. . (2023). Psychiatric symptoms in long-COVID patients: a systematic review. Front. Psych. 14:1138389. doi: 10.3389/fpsyt.2023.1138389</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2023.1138389</ArticleId><ArticleId IdType="pmc">PMC10320160</ArticleId><ArticleId IdType="pubmed">37415689</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjenberg Z., Leng S., Tascini C., Garg M., Misso K., El Guerche Seblain C., et al. . (2023). Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysis. Sci. Rep. 13:15332. doi: 10.1038/s41598-023-42321-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-42321-9</ArticleId><ArticleId IdType="pmc">PMC10504382</ArticleId><ArticleId IdType="pubmed">37714919</ArticleId></ArticleIdList></Reference><Reference><Citation>Navis A. (2023). A review of neurological symptoms in long COVID and clinical management. Semin. Neurol. 43, 286&#x2013;296. doi: 10.1055/s-0043-1767781, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1767781</ArticleId><ArticleId IdType="pubmed">37068519</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L. L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., et al. . (2023). The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 55:101762. doi: 10.1016/j.eclinm.2022.101762, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Giraldo G. S., Ali S. T., Kang A. K., Patel T. R., Budhiraja S., Gaelen J. I., et al. . (2023). Neurologic manifestations of long COVID differ based on acute COVID-19 severity. Ann. Neurol. 94, 146&#x2013;159. doi: 10.1002/ana.26649, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26649</ArticleId><ArticleId IdType="pmc">PMC10724021</ArticleId><ArticleId IdType="pubmed">36966460</ArticleId></ArticleIdList></Reference><Reference><Citation>Rofail D., Somersan-Karakaya S., Choi J. Y., Przydzial K., Zhao Y., Hussein M., et al. . (2024). Thematic analysis to explore patients&#x2019; experiences with long COVID-19: a conceptual model of symptoms and impacts on daily lives. BMJ Open. 14:e076992. doi: 10.1136/bmjopen-2023-076992, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-076992</ArticleId><ArticleId IdType="pmc">PMC10806796</ArticleId><ArticleId IdType="pubmed">38233059</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero M., Caicedo M., D&#xed;az A., Ortega D., Llanos C., Concha A., et al. . (2023). Post-COVID-19 syndrome: descriptive analysis based on a survivors&#x2019; cohort in Colombia. Global Epidemiol. 6:100126. doi: 10.1016/j.gloepi.2023.100126, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gloepi.2023.100126</ArticleId><ArticleId IdType="pmc">PMC10643089</ArticleId><ArticleId IdType="pubmed">38023981</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakhamuri S. M., Jankie S., Pinto Pereira L. M. (2022). Calling on Latin America and the Caribbean countries to recognise the disability from long COVID. Lancet Regional Health-Americas. 15:100362. doi: 10.1016/j.lana.2022.100362, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2022.100362</ArticleId><ArticleId IdType="pmc">PMC9412073</ArticleId><ArticleId IdType="pubmed">36043156</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos Guedes De Sa K., Silva J., Bayarri-Olmos R., Brinda R., Alec Rath Constable R., Colom Diaz P. A., et al. . (2024). A causal link between autoantibodies and neurological symptoms in long COVID. medRxiv. [Preprint]. doi: 10.1101/2024.06.18.24309100</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.06.18.24309100</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., et al. . (2022). Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 9, 815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Terwee C. B., Peipert J. D., Chapman R., Lai J.-S., Terluin B., Cella D., et al. . (2021). Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures. Qual. Life Res. 30, 2729&#x2013;2754. doi: 10.1007/s11136-021-02925-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02925-y</ArticleId><ArticleId IdType="pmc">PMC8481206</ArticleId><ArticleId IdType="pubmed">34247326</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S., Di Lorenzo F., Scarioni M., Frederiksen K. S., Nobili F. (2021). Is the frontal lobe the primary target of SARS-CoV-2? JAD. 81, 75&#x2013;81. doi: 10.3233/JAD-210008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210008</ArticleId><ArticleId IdType="pubmed">33720900</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe9;lez-Santamar&#xed;a R., Fern&#xe1;ndez-Solana J., M&#xe9;ndez-L&#xf3;pez F., Dom&#xed;nguez-Garc&#xed;a M., Gonz&#xe1;lez-Bernal J. J., Magall&#xf3;n-Botaya R., et al. . (2023). Functionality, physical activity, fatigue and quality of life in patients with acute COVID-19 and long COVID infection. Sci. Rep. 13:19907. doi: 10.1038/s41598-023-47218-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-47218-1</ArticleId><ArticleId IdType="pmc">PMC10645778</ArticleId><ArticleId IdType="pubmed">37963962</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L., Zhu C., Orban Z., Yarnoff K., Palacio N., Jimenez M., et al. . (2023). Autoantibody production is enhanced after mild SARS-CoV-2 infection despite vaccination in individuals with and without long COVID. medRxiv. [Preprint]. doi: 10.1101/2023.04.07.23288243</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.04.07.23288243</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Elm E., Altman D. G., Egger M., Pocock S. J., G&#xf8;tzsche P. C., Vandenbroucke J. P. (2008). The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J. Clin. Epidemiol. 61, 344&#x2013;349. doi: 10.1016/j.jclinepi.2007.11.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.11.008</ArticleId><ArticleId IdType="pubmed">18313558</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S., Dikmen S. S., Heaton R. K., Tulsky D. S., Zelazo P. D., Bauer P. J., et al. . (2013). Cognition assessment using the NIH toolbox. Neurology. 80, S54&#x2013;S64. doi: 10.1212/WNL.0b013e3182872ded, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182872ded</ArticleId><ArticleId IdType="pmc">PMC3662346</ArticleId><ArticleId IdType="pubmed">23479546</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . (2021). COVID-19 clinical management: living guidance, 25 January 2021. Available at: https://iris.who.int/handle/10665/338882 (Accessed April 18, 2024).</Citation></Reference><Reference><Citation>Yang J., Markus K., Andersen K. M., Rudolph A. E., McGrath L. J., Nguyen J. L., et al. . (2024). Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review. BMJ Open. 14:e077886. doi: 10.1136/bmjopen-2023-077886, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-077886</ArticleId><ArticleId IdType="pmc">PMC10806676</ArticleId><ArticleId IdType="pubmed">38233057</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>